{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:06:33Z","timestamp":1787069193545,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T00:00:00Z","timestamp":1487635200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00210-017-1361-8","type":"journal-article","created":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T19:32:16Z","timestamp":1487619136000},"page":"613-619","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Rho kinase inhibition ameliorates cyclophosphamide-induced cystitis in rats"],"prefix":"10.1007","volume":"390","author":[{"given":"Andrzej","family":"Wr\u00f3bel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urszula","family":"Doboszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Rechberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Rojek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Serefko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Poleszak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystyna","family":"Skalicka-Wo\u017aniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw","family":"Dudka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Wla\u017a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,21]]},"reference":[{"key":"1361_CR1","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/luts.12058","volume":"7","author":"Y Akin","year":"2015","unstructured":"Akin Y, Bozkurt A, Erol HS, Halici M, Celebi F, Kapakin KA, Gulmez H, Ates M, Coban A, Nuhoglu B (2015) Impact of Rho-kinase inhibitor hydroxyfasudil in protamine sulphate induced cystitis rat bladder. Low Urin Tract Symptoms 7:108\u2013114","journal-title":"Low Urin Tract Symptoms"},{"key":"1361_CR2","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/S0024-3205(01)01182-1","volume":"69","author":"TW Cannon","year":"2001","unstructured":"Cannon TW, Damaser MS (2001) Effects of anesthesia on cystometry and leak point pressure of the female rat. Life Sci 69:1193\u20131202","journal-title":"Life Sci"},{"key":"1361_CR3","first-page":"51","volume":"8","author":"K Dimitropoulos","year":"2016","unstructured":"Dimitropoulos K, Gravas S (2016) New therapeutic strategies for the treatment of male lower urinary tract symptoms. Res Rep Urol 8:51\u201359","journal-title":"Res Rep Urol"},{"key":"1361_CR4","doi-asserted-by":"publisher","first-page":"592","DOI":"10.5604\/17322693.1009703","volume":"66","author":"L Dobrek","year":"2012","unstructured":"Dobrek L, Thor PJ (2012) Bladder urotoxicity pathophysiology induced by the oxazaphosphorine alkylating agents and its chemoprevention. Postepy Hig Med Dosw 66:592\u2013602","journal-title":"Postepy Hig Med Dosw"},{"key":"1361_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1124\/jpet.106.110635","volume":"320","author":"C Doe","year":"2007","unstructured":"Doe C, Bentley R, Behm DJ, Lafferty R, Stavenger R, Jung D, Bamford M, Panchal T, Grygielko E, Wright LL, Smith GK, Chen Z, Webb C, Khandekar S, Yi T, Kirkpatrick R, Dul E, Jolivette L, Marino JP Jr, Willette R, Lee D, Hu E (2007) Novel Rho kinase inhibitors with anti-inflammatory and vasodilatory activities. J Pharmacol Exp Ther 320:89\u201398","journal-title":"J Pharmacol Exp Ther"},{"key":"1361_CR6","first-page":"D15","volume":"10","author":"T Ebiloglu","year":"2016","unstructured":"Ebiloglu T, Kaya E, Yilmaz S, \u00d6zg\u00fcr G, Kibar Y (2016) Treatment of resistant cyclophosphamide induced haemorrhagic cystitis: review of literature and three case reports. J Clin Diagn Res 10:D15\u2013D16","journal-title":"J Clin Diagn Res"},{"key":"1361_CR7","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","volume":"6","author":"A Emadi","year":"2009","unstructured":"Emadi A, Jones RJ, Brodsky RA (2009) Cyclophosphamide and cancer: golden anniversary. Nat Rev Clin Oncol 6:638\u2013647","journal-title":"Nat Rev Clin Oncol"},{"key":"1361_CR8","first-page":"1103","volume":"28","author":"TN Gomes","year":"1995","unstructured":"Gomes TN, Santos CC, Souza-Filho MV, Cunha FQ, Ribeiro RA (1995) Participation of TNF-alpha and IL-1 in the pathogenesis of cyclophosphamide-induced hemorrhagic cystitis. Braz J Med Biol Res 28:1103\u20131108","journal-title":"Braz J Med Biol Res"},{"issue":"Suppl 2","key":"1361_CR9","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1038\/sj.bjp.0706560","volume":"147","author":"SS Hegde","year":"2006","unstructured":"Hegde SS (2006) Muscarinic receptors in the bladder: from basic research to therapeutics. Br J Pharmacol 147(Suppl 2):S80\u2013S87","journal-title":"Br J Pharmacol"},{"key":"1361_CR10","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1089\/jmf.2015.0077","volume":"19","author":"S Hidalgo-Lucas","year":"2016","unstructured":"Hidalgo-Lucas S, Rozan P, Gu\u00e9rin-Deremaux L, Baert B, Violle N, Saniez-Degrave MH, Bisson JF (2016) Benefits of preventive administration of Chlorella sp. on visceral pain and cystitis induced by a single administration of cyclophosphamide in female Wistar rat. J Med Food 19:450\u2013456","journal-title":"J Med Food"},{"key":"1361_CR11","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s00018-016-2136-y","volume":"73","author":"PL Hordijk","year":"2016","unstructured":"Hordijk PL (2016) Recent insights into endothelial control of leukocyte extravasation. Cell Mol Life Sci 73:1591\u20131608","journal-title":"Cell Mol Life Sci"},{"key":"1361_CR12","first-page":"477","volume":"61","author":"K Juszczak","year":"2010","unstructured":"Juszczak K, Gil K, Wyczolkowski M, Thor PJ (2010) Functional, histological structure and mastocytes alterations in rat urinary bladders following acute and chronic cyclophosphamide treatment. J Physiol Pharmacol 61:477\u2013482","journal-title":"J Physiol Pharmacol"},{"key":"1361_CR13","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","volume":"18","author":"M Karin","year":"2000","unstructured":"Karin M, Ben-Neriah Y (2000) Phosphorylation meets ubiquitination: the control of NF-\u03baB activity. Annu Rev Immunol 18:621\u2013663","journal-title":"Annu Rev Immunol"},{"key":"1361_CR14","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1016\/j.peptides.2009.07.025","volume":"30","author":"M Kobayashi","year":"2009","unstructured":"Kobayashi M, Nomura M, Fujihara H, Suzuki H, Otsubo H, Nishii H, Fujimoto N, Matsumoto T, Ueta Y (2009) Involvement of orexin-A on micturition reflex in normal and cyclophosphamide-induced cystitis bladder in rat. Peptides 30:2348\u20132356","journal-title":"Peptides"},{"key":"1361_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10565-006-0078-0","volume":"23","author":"A Korkmaz","year":"2007","unstructured":"Korkmaz A, Topal T, Oter S (2007) Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation. Cell Biol Toxicol 23:303\u2013312","journal-title":"Cell Biol Toxicol"},{"key":"1361_CR16","doi-asserted-by":"publisher","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence T (2009) The nuclear factor NF-\u03baB pathway in inflammation. Cold Spring Harb Perspect Biol 1:a001651","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1361_CR17","first-page":"473536","volume":"2014","author":"G Lee","year":"2014","unstructured":"Lee G, Romih R, Zupancic D (2014) Cystitis: from urothelial cell biology to clinical applications. Biomed Res Int 2014:473536","journal-title":"Biomed Res Int"},{"key":"1361_CR18","doi-asserted-by":"publisher","first-page":"704","DOI":"10.2174\/156802609789044452","volume":"9","author":"PV LoGrasso","year":"2009","unstructured":"LoGrasso PV, Feng Y (2009) Rho kinase (ROCK) inhibitors and their application to inflammatory disorders. Curr Top Med Chem 9:704\u2013723","journal-title":"Curr Top Med Chem"},{"key":"1361_CR19","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/j.1442-2042.2009.02375.x","volume":"16","author":"T Masago","year":"2009","unstructured":"Masago T, Watanabe T, Saito M, Kinoshita Y, Sato K, Miyagawa I (2009) Effect of the rho-kinase inhibitor hydroxyfasudil on bladder overactivity: an experimental rat model. Int J Urol 16:842\u2013847","journal-title":"Int J Urol"},{"key":"1361_CR20","doi-asserted-by":"publisher","unstructured":"Matz EL, Hsieh MH (2017) Review of advances in uroprotective agents for cyclophosphamide and ifosfamide-induced hemorrhagic cystitis. Urology 100:16\u201319","DOI":"10.1016\/j.urology.2016.07.030"},{"key":"1361_CR21","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/bju.12291","volume":"112","author":"H Payne","year":"2013","unstructured":"Payne H, Adamson A, Bahl A, Borwell J, Dodds D, Heath C, Huddart R, McMenemin R, Patel P, Peters JL, Thompson A (2013) Chemical- and radiation-induced haemorrhagic cystitis: current treatments and challenges. BJU Int 112:885\u2013897","journal-title":"BJU Int"},{"key":"1361_CR22","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/S0016-5085(03)00283-X","volume":"124","author":"JP Segain","year":"2003","unstructured":"Segain JP, Raingeard dB, Sauzeau V, Bourreille A, Hilaret G, Cario-Toumaniantz C, Pacaud P, Galmiche JP, Loirand G (2003) Rho kinase blockade prevents inflammation via nuclear factor \u03baB inhibition: evidence in Crohn\u2019s disease and experimental colitis. Gastroenterology 124:1180\u20131187","journal-title":"Gastroenterology"},{"key":"1361_CR23","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/iju.12119","volume":"20","author":"N Shimizu","year":"2013","unstructured":"Shimizu N, De Velasco MA, Umekawa T, Uemura H, Yoshikawa K (2013) Effects of the Rho kinase inhibitor, hydroxyfasudil, on bladder dysfunction and inflammation in rats with HCl-induced cystitis. Int J Urol 20:1136\u20131143","journal-title":"Int J Urol"},{"key":"1361_CR24","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.2337\/db11-1763","volume":"61","author":"Z Wang","year":"2012","unstructured":"Wang Z, Cheng Z, Cristofaro V, Li J, Xiao X, Gomez P, Ge R, Gong E, Strle K, Sullivan MP, Adam RM, White MF, Olumi AF (2012) Inhibition of TNF-\u03b1 improves the bladder dysfunction that is associated with type 2 diabetes. Diabetes 61:2134\u20132145","journal-title":"Diabetes"},{"key":"1361_CR25","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/j.1464-410X.1973.tb12230.x","volume":"45","author":"NA Watson","year":"1973","unstructured":"Watson NA, Notley RG (1973) Urological complications of cyclophosphamide. Br J Urol 45:606\u2013609","journal-title":"Br J Urol"},{"key":"1361_CR26","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/sj.bjp.0705109","volume":"138","author":"A Wibberley","year":"2003","unstructured":"Wibberley A, Chen Z, Hu E, Hieble JP, Westfall TD (2003) Expression and functional role of Rho-kinase in rat urinary bladder smooth muscle. Br J Pharmacol 138:757\u2013766","journal-title":"Br J Pharmacol"},{"key":"1361_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/nau.22918","author":"A Wr\u00f3bel","year":"2015","unstructured":"Wr\u00f3bel A, Rechberger T (2015) The influence of Rho-kinase inhibition on acetic acid-induced detrusor overactivity. Neurourol Urodyn. doi: 10.1002\/nau.22918","journal-title":"Neurourol Urodyn"},{"key":"1361_CR28","first-page":"225","volume":"93","author":"A Wr\u00f3bel","year":"2016","unstructured":"Wr\u00f3bel A, Rechberger T (2016a) Ovariectomy may induce detrusor overactivity in rats: the therapeutic role of Rho kinase inhibition. Urology 93:225\u2013227","journal-title":"Urology"},{"key":"1361_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/nau.22978","author":"A Wr\u00f3bel","year":"2016","unstructured":"Wr\u00f3bel A, Rechberger T (2016b) The effect of combined treatment with a \u03b23AR agonist and a ROCK inhibitor on detrusor overactivity. Neurourol Urodyn. doi: 10.1002\/nau.22978","journal-title":"Neurourol Urodyn"},{"key":"1361_CR30","doi-asserted-by":"publisher","first-page":"224.e7","DOI":"10.1016\/j.urology.2016.03.008","volume":"93","author":"A Wr\u00f3bel","year":"2016","unstructured":"Wr\u00f3bel A, Rechberger T (2016c) The influence of maxacalcitol, vitamin D3 analog, on detrusor overactivity in conscious rats. Urology 93:224.e7\u2013224.e15","journal-title":"Urology"},{"key":"1361_CR31","first-page":"364","volume":"79","author":"A Wr\u00f3bel","year":"2008","unstructured":"Wr\u00f3bel A, Adamiak A, Skorupski P, Rechberger T (2008) Rho kinase\u2014a new target for pharmacological treatment of an overactive bladder. Ginekol Pol 79:364\u2013369","journal-title":"Ginekol Pol"},{"key":"1361_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.vascn.2015.04.006","volume":"74","author":"A Wr\u00f3bel","year":"2015","unstructured":"Wr\u00f3bel A, \u0141a\u0144cut M, Rechberger T (2015) A new model of detrusor overactivity in conscious rats induced by retinyl acetate instillation. J Pharmacol Toxicol Methods 74:7\u201316","journal-title":"J Pharmacol Toxicol Methods"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-017-1361-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-017-1361-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-017-1361-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T11:42:04Z","timestamp":1719056524000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-017-1361-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,21]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["1361"],"URL":"https:\/\/doi.org\/10.1007\/s00210-017-1361-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,21]]}}}